Market Overview

The Global Fluorescent In Situ Hybridization Market was valued at USD 892.5 million in 2023 and is expected to reach USD 1,603.7 million by 2031 while growing at a CAGR of 7.6% during the forecast period (2024-2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global Fluorescent In Situ hybridization market growth. Fluorescent In Situ Hybridization (FISH) visualizes DNA sequences on chromosomes using fluorescent probes, aiding in gene mapping, identifying abnormalities, and studying gene expression. Widely applied in genetics and cancer research, FISH provides crucial insights into the organization and behavior of genetic material within cells.

The rising incidence of genetic disorders and cancer, coupled with ongoing advancements in molecular biology techniques, is set to drive the global fluorescent In Situ hybridization market. However, challenges such as stringent regulatory requirements for FISH probes and equipment approval may impede market expansion.

Furthermore, the global fluorescent In Situ hybridization industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Product Type Analysis

The Global Fluorescent In Situ Hybridization Market is segmented among Analytical Instrument, Kits & Reagents, and Software & Services, based on Product Type. In 2023, Analytical Instrument accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Application Analysis

The Global Fluorescent In Situ Hybridization Market is segmented among Cancer, Genetic Diseases, and Others, based on Application. In 2023, Cancer accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Fluorescent In Situ Hybridization Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Abnova Corporation, Agilent Technologies, Biocare Medical, LLC, Biodot Inc., F. HOFFMANN-LA ROCHE LTD., Genemed Technologies, Inc., Merck KGaA, PERKINELMER INC, Qiagen (Exiqon A/S), and ThermoFisher Scientific Inc.

 Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Fluorescent In Situ Hybridization Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Fluorescent In Situ Hybridization Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Fluorescent In Situ Hybridization Market Segmentation, By Product Type

• Global Fluorescent In Situ Hybridization Market Share Analysis, By Product Type

• Global Fluorescent In Situ Hybridization Market Growth Analysis, By Product Type

• Global Fluorescent In Situ Hybridization Market Trends, By Product Type

o Analytical Instrument

o Kits & Reagents

o Software & Services

6. Global Fluorescent In Situ Hybridization Market Segmentation, By Application

• Global Fluorescent In Situ Hybridization Market Share Analysis, By Application

• Global Fluorescent In Situ Hybridization Market Growth Analysis, By Application

• Global Fluorescent In Situ Hybridization Market Trends, By Application

o Cancer

o Genetic Diseases

o Others

7. Global Fluorescent In Situ Hybridization Market Segmentation, By Region

• Global Fluorescent In Situ Hybridization Market Share Analysis, By Region

• Global Fluorescent In Situ Hybridization Market Growth Analysis, By Region

• Global Fluorescent In Situ Hybridization Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Abnova Corporation*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Agilent Technologies

• Biocare Medical, LLC

• Biodot Inc.

• F. HOFFMANN-LA ROCHE LTD.

• Genemed Technologies, Inc.

• Merck KGaA

• PERKINELMER INC

• Qiagen (Exiqon A/S)

• ThermoFisher Scientific Inc.

*Similar analysis will be provided for each company listed above.